Clinical Trials List
Protocol NumberMO42541
Active
2021-06-01 - 2026-12-31
Phase III
Recruiting2
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Ann-Lii Cheng Division of Hematology & Oncology
- 呂理駿 Division of Hematology & Oncology
- 曾岱宗 Division of General Internal Medicine
- 莊建淮 Division of Hematology & Oncology
- Ying-Chun Shen Division of Hematology & Oncology
- 郭弘揚 Division of Hematology & Oncology
- Shih-Jer Hsu Division of General Internal Medicine
- YU-YUN SHAO Division of Hematology & Oncology
- 楊宏志 Division of Hematology & Oncology
- 林宗哲 Division of Hematology & Oncology
- Chiun Hsu Division of Hematology & Oncology
- TSUNG-HAO LIU Division of Hematology & Oncology
- 蘇東弘 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20-30 participants
-
Global
554 participants
